1. Home
  2. AGIO vs SNDA Comparison

AGIO vs SNDA Comparison

Compare AGIO & SNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$28.09

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Sonida Senior Living Inc.

SNDA

Sonida Senior Living Inc.

HOLD

Current Price

$37.18

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIO
SNDA
Founded
2007
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
2013
1997

Fundamental Metrics

Financial Performance
Metric
AGIO
SNDA
Price
$28.09
$37.18
Analyst Decision
Buy
Buy
Analyst Count
8
4
Target Price
$38.88
$35.75
AVG Volume (30 Days)
856.8K
636.9K
Earning Date
04-29-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,011,000.00
$381,141,000.00
Revenue This Year
$76.75
$68.73
Revenue Next Year
$170.73
$11.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
25.24
52 Week Low
$22.24
$23.66
52 Week High
$46.00
$39.66

Technical Indicators

Market Signals
Indicator
AGIO
SNDA
Relative Strength Index (RSI) 47.91 52.44
Support Level $26.42 $30.78
Resistance Level $29.37 $38.74
Average True Range (ATR) 0.94 1.91
MACD 0.16 -0.20
Stochastic Oscillator 61.05 60.37

Price Performance

Historical Comparison
AGIO
SNDA

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

About SNDA Sonida Senior Living Inc.

Sonida Senior Living Inc is an owner-operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic services offered by the company at its senior housing communities comprise meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.

Share on Social Networks: